Andrew L Clark
Overview
Explore the profile of Andrew L Clark including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
360
Citations
4539
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Monzo L, Kobayashi M, Ferreira J, Lamiral Z, Delles C, Clark A, et al.
Cardiovasc Diabetol
. 2025 Mar;
24(1):111.
PMID: 40057728
Background: Coronary artery disease (CAD) and diabetes mellitus (DM) can induce changes in myocardial structure and function, thereby increasing the risk of heart failure (HF). We aimed to identify the...
2.
Rezig A, Morsy M, Caiazzo E, Iaconelli A, Ialenti A, Hunter D, et al.
ESC Heart Fail
. 2025 Mar;
PMID: 40024803
Background: The neutrophil-to-lymphocyte ratio (NLR) may be a useful marker of inflammation, but its associations with clinical characteristics, signs of congestion and outcome in patients with chronic heart failure (HF)...
3.
Barnes-Harris M, Datla S, Abel A, Clark A, Johnson M
PLoS One
. 2024 Dec;
19(12):e0314631.
PMID: 39739958
Background: Care planning with people with advanced heart failure enables appropriate care, and prevents futile interventions, such as cardio-pulmonary resuscitation (CPR). Aim: To explore what motivates clinicians to conduct, and...
4.
Dieden A, Girerd N, Ottosson F, Molvin J, Pareek M, Melander O, et al.
Eur J Heart Fail
. 2024 Oct;
PMID: 39466935
Aims: Biomarkers associated with asymptomatic ventricular dysfunction might improve risk stratification and identify pathways leading to heart failure (HF). We explored the association between proteomic biomarkers and left ventricular hypertrophy...
5.
Cleland J, Pellicori P, Graham F, Lane R, Petrie M, Ahmed F, et al.
J Am Coll Cardiol
. 2024 Oct;
84(18):1704-1717.
PMID: 39443013
Background: Patients with heart failure and iron deficiency have diverse causes for hospitalization and death that might be affected by iron repletion. Objectives: The purpose of this study was to...
6.
Valentova M, Vatic M, Garfias-Veitl T, Sandek A, Bekfani T, Jankowska E, et al.
Diabetes Res Clin Pract
. 2024 Sep;
217:111864.
PMID: 39304136
Aims: Diabetes mellitus (DM) and heart failure (HF) share vascular, skeletal and metabolic abnormalities that can reduce exercise capacity. We investigated whether exercise capacity differ in patients with type 2...
7.
Wei F, Pellicori P, Ferreira J, Gonzalez A, Mariottoni B, An D, et al.
Hypertens Res
. 2024 Sep;
47(11):3225-3236.
PMID: 39242826
None of the spironolactone trials in heart failure (HF) assessed the blood pressure (BP) responses to exercise, while conflicting results were reported for exercise capacity. In the HOMAGE trial, 527...
8.
Wei F, Mariottoni B, An D, Pellicori P, Yu Y, Verdonschot J, et al.
ESC Heart Fail
. 2024 Aug;
11(6):4116-4126.
PMID: 39129059
Aims: Few randomized trials assessed the changes over time in the chronotropic heart rate (HR) reactivity (CHR), HR recovery (HRR) and exercise endurance (EE) in response to the incremental shuttle...
9.
Cannata A, Mizani M, Bromage D, Piper S, Hardman S, Sudlow C, et al.
JACC Heart Fail
. 2024 Aug;
13(3):402-413.
PMID: 39115521
Background: For patients with acute heart failure (HF), specialist HF care during admission improves diagnosis and treatments. Objectives: The authors aimed to investigate the association of HF specialist care with...
10.
Kazmi S, Kambhampati C, Rigby A, Cleland J, Kazmi K, Cuthbert J, et al.
Eur J Heart Fail
. 2024 Aug;
PMID: 39105488
Aims: Understanding the pattern of disease progression in chronic heart failure (HF) may inform patient care and healthcare system design. We used a four-state Markov model to describe the disease...